METASTATIC PANCREATIC CANCER
Clinical trials for METASTATIC PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo tackles tough pancreatic cancer
Disease control CompletedThis study tested an experimental immunotherapy called indoximod added to standard chemotherapy (gemcitabine and nab-paclitaxel) in 157 people with metastatic pancreatic cancer. The goal was to find a safe dose and see if the combination helps people live longer. The trial has co…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE1, PHASE2 • Sponsor: NewLink Genetics Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New pill plus chemo shows early promise in tough pancreatic cancer
Disease control CompletedThis early-phase trial tested an experimental oral drug called IOA-289 combined with standard chemotherapy (gemcitabine and nab-paclitaxel) in 16 people with metastatic pancreatic cancer. The main goal was to check safety and find the right dose. Researchers also looked at how th…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE1, PHASE2 • Sponsor: iOnctura • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New combo targets DNA repair to fight pancreatic cancer
Disease control CompletedThis study tested a new combination of drugs (ABT-888 plus chemotherapy) in 64 people with pancreatic cancer that had spread. The goal was to see if adding ABT-888, which blocks cancer cells from fixing DNA damage, could make chemotherapy work better and shrink tumors. The study …
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE1, PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Experimental combo targets tough cancers
Disease control CompletedThis study tested an experimental drug called BMS-813160, given together with chemotherapy or the immunotherapy nivolumab (Opdivo), in 332 people with advanced colorectal or pancreatic cancer. The main goals were to check safety, side effects, and how the body processes the drug,…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Blood tests and surveys may predict cancer treatment success
Knowledge-focused CompletedThis study followed 159 people with metastatic colorectal, pancreatic, biliary, or esophageal cancers who were starting a new line of therapy. Researchers collected blood samples (tumor markers and liquid biopsies) and patient-reported quality-of-life data to see if these could p…
Matched conditions: METASTATIC PANCREATIC CANCER
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Real-World chemotherapy patterns in advanced pancreatic cancer revealed
Knowledge-focused CompletedThis study observed 799 adults with advanced or metastatic pancreatic cancer in Korea to see which chemotherapy treatments doctors actually use and why. Researchers tracked treatment choices, survival times, and quality of life. The goal was to understand real-world practice, not…
Matched conditions: METASTATIC PANCREATIC CANCER
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:16 UTC